MohammedBariMD

Clinical Trials

• Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects Start of enrollment: 2008 Sep 01

  Terminated

  Phase 2

• Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression Start of enrollment: 2010 Nov 01

  Completed

  Phase 2

• A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) Start of enrollment: 2011 Feb 01

  Completed

  Phase 2, Phase 3

• Major Depressive Disorder With Mixed Features Start of enrollment: 2012 Jan 01

  Withdrawn

  Phase 3

• Major Depressive Disorder With Mixed Features - Extension Start of enrollment: 2011 Sep 01

  Completed

  Phase 3

• PEARL Schizophrenia Maintenance Start of enrollment: 2011 Sep 01

  Completed

  Phase 3

• Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD) Start of enrollment: 2013 Oct 01

  Completed

  Phase 2

• PRC-063 in Adolescent ADHD Start of enrollment: 2014 Apr 01

  Completed

  Phase 3

• Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD Start of enrollment: 2014 May 01

  Completed

  Phase 3

• Dasotraline Pediatric ADHD Study Start of enrollment: 2015 Apr 01

  Completed

  Phase 2, Phase 3

• This Study Tests Whether BI 425809 Together With Brain Training Using a Computer Improves Mental Functioning in Patients With Schizophrenia Start of enrollment: 2019 Apr 15

  Completed

  Phase 2

• Join now to see all